Family · Pharmaceutical analytical standards
Kanamycin
An aminoglycoside antibiotic isolated in 1957 by the Japanese microbiologist Hamao Umezawa from the bacterium Streptomyces kanamyceticus: it is active against many Gram-negative bacteria and the tuberculosis bacillus. This family brings together the active ingredient, pharmacopoeial impurities, labelled standards and other impurities.
Did you know?In molecular biology it is a classic: the KanR resistance gene, which disables the antibiotic by adding a phosphate group to it, is used to select bacteria that have taken up a plasmid.
No product matches your search.
EDQM standards 2
The official European Pharmacopoeia standards for this family.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.
